Human brain imaging in HIV and neuroAIDS

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The introduction of combination antiretroviral therapy (cART) has significantly decreased the severity of HIV-associated neurocognitive disorder (HAND) and increased the life expectancy of the human immunodeficiency virus (HIV) positive population. Nevertheless, patients still show persistent neurocognitive disorders due to associated structural and functional brain changes. The purpose of this chapter is to highlight the significance of brain neuroimaging techniques and biomarkers in understanding the pathophysiology related to HIV infection and HAND. These imaging modalities include volumetric (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography (PET), single-photon emission computed tomography (SPECT), diffusion tensor imaging (DTI), arterial spin labeling (ASL), and perfusion MRI. The authors predict that with neuroimaging advances at the molecular level, it will soon be the noninvasive gold standard in brain pathology diagnosis.

Original languageEnglish (US)
Title of host publicationGlobal Virology II - HIV and NeuroAIDS
PublisherSpringer New York
Pages93-110
Number of pages18
ISBN (Electronic)9781493972906
ISBN (Print)9781493972883
DOIs
StatePublished - Jan 1 2017

Fingerprint

Neuroimaging
HIV
Brain
Diffusion Tensor Imaging
Virus Diseases
Life Expectancy
Single-Photon Emission-Computed Tomography
Positron-Emission Tomography
Magnetic Resonance Spectroscopy
Perfusion
Biomarkers
Pathology
Neuroaid
Population
Neurocognitive Disorders
Therapeutics

Keywords

  • Biomarkers
  • Brain
  • DTI
  • HAND
  • HIV
  • Imaging
  • MRI
  • MRS
  • NeuroAIDS
  • PET

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Mohamed, M. (2017). Human brain imaging in HIV and neuroAIDS. In Global Virology II - HIV and NeuroAIDS (pp. 93-110). Springer New York. https://doi.org/10.1007/978-1-4939-7290-6_6

Human brain imaging in HIV and neuroAIDS. / Mohamed, Mona.

Global Virology II - HIV and NeuroAIDS. Springer New York, 2017. p. 93-110.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mohamed, M 2017, Human brain imaging in HIV and neuroAIDS. in Global Virology II - HIV and NeuroAIDS. Springer New York, pp. 93-110. https://doi.org/10.1007/978-1-4939-7290-6_6
Mohamed M. Human brain imaging in HIV and neuroAIDS. In Global Virology II - HIV and NeuroAIDS. Springer New York. 2017. p. 93-110 https://doi.org/10.1007/978-1-4939-7290-6_6
Mohamed, Mona. / Human brain imaging in HIV and neuroAIDS. Global Virology II - HIV and NeuroAIDS. Springer New York, 2017. pp. 93-110
@inbook{ea8a498664cd46fb92a62829c4be9ac8,
title = "Human brain imaging in HIV and neuroAIDS",
abstract = "The introduction of combination antiretroviral therapy (cART) has significantly decreased the severity of HIV-associated neurocognitive disorder (HAND) and increased the life expectancy of the human immunodeficiency virus (HIV) positive population. Nevertheless, patients still show persistent neurocognitive disorders due to associated structural and functional brain changes. The purpose of this chapter is to highlight the significance of brain neuroimaging techniques and biomarkers in understanding the pathophysiology related to HIV infection and HAND. These imaging modalities include volumetric (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography (PET), single-photon emission computed tomography (SPECT), diffusion tensor imaging (DTI), arterial spin labeling (ASL), and perfusion MRI. The authors predict that with neuroimaging advances at the molecular level, it will soon be the noninvasive gold standard in brain pathology diagnosis.",
keywords = "Biomarkers, Brain, DTI, HAND, HIV, Imaging, MRI, MRS, NeuroAIDS, PET",
author = "Mona Mohamed",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7290-6_6",
language = "English (US)",
isbn = "9781493972883",
pages = "93--110",
booktitle = "Global Virology II - HIV and NeuroAIDS",
publisher = "Springer New York",

}

TY - CHAP

T1 - Human brain imaging in HIV and neuroAIDS

AU - Mohamed, Mona

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The introduction of combination antiretroviral therapy (cART) has significantly decreased the severity of HIV-associated neurocognitive disorder (HAND) and increased the life expectancy of the human immunodeficiency virus (HIV) positive population. Nevertheless, patients still show persistent neurocognitive disorders due to associated structural and functional brain changes. The purpose of this chapter is to highlight the significance of brain neuroimaging techniques and biomarkers in understanding the pathophysiology related to HIV infection and HAND. These imaging modalities include volumetric (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography (PET), single-photon emission computed tomography (SPECT), diffusion tensor imaging (DTI), arterial spin labeling (ASL), and perfusion MRI. The authors predict that with neuroimaging advances at the molecular level, it will soon be the noninvasive gold standard in brain pathology diagnosis.

AB - The introduction of combination antiretroviral therapy (cART) has significantly decreased the severity of HIV-associated neurocognitive disorder (HAND) and increased the life expectancy of the human immunodeficiency virus (HIV) positive population. Nevertheless, patients still show persistent neurocognitive disorders due to associated structural and functional brain changes. The purpose of this chapter is to highlight the significance of brain neuroimaging techniques and biomarkers in understanding the pathophysiology related to HIV infection and HAND. These imaging modalities include volumetric (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography (PET), single-photon emission computed tomography (SPECT), diffusion tensor imaging (DTI), arterial spin labeling (ASL), and perfusion MRI. The authors predict that with neuroimaging advances at the molecular level, it will soon be the noninvasive gold standard in brain pathology diagnosis.

KW - Biomarkers

KW - Brain

KW - DTI

KW - HAND

KW - HIV

KW - Imaging

KW - MRI

KW - MRS

KW - NeuroAIDS

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=85042606442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042606442&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7290-6_6

DO - 10.1007/978-1-4939-7290-6_6

M3 - Chapter

AN - SCOPUS:85042606442

SN - 9781493972883

SP - 93

EP - 110

BT - Global Virology II - HIV and NeuroAIDS

PB - Springer New York

ER -